Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 8.7B | 9.2B | 9.0B | 9.2B |
Cost of revenue | 3.5B | 3.9B | 3.9B | 3.8B |
Gross profit | 5.1B | 5.4B | 5.1B | 5.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.4B | 4.5B | 4.4B | 4.5B |
Other operating expenses | — | — | — | — |
Operating income | 731.2M | 820.6M | 745.5M | 870.2M |
Non operating interest income | ||||
Income | 23.2M | 11.5M | 7.1M | 4.4M |
Expense | 89.8M | 99.3M | 89.6M | 108.6M |
Other income expense | 41.1M | 108.2M | -274.8M | 206.7M |
Pretax income | 705.7M | 841M | 388.2M | 972.7M |
Tax provision | 107.2M | 177.4M | 187.8M | 20.7M |
Net income | 598.5M | 663.6M | 200.4M | 952M |
Basic EPS | 10.7 | 10.9 | 3.1 | 13.5 |
Diluted EPS | 10.6 | 10.8 | 3.0 | 13.3 |
Basic average shares | 56M | 65.8M | 68.4M | 73.7M |
Diluted average shares | 56M | 65.8M | 68.4M | 73.7M |
EBITDA | 1.1B | 1.2B | 1.2B | 1.4B |
Net income from continuing op. | 598.5M | 663.6M | 200.4M | 952M |
Minority interests | — | 0 | 0 | 300K |
Preferred stock dividends | — | — | — | — |